Publications
Publishing the Frontiers of Immuno-Oncology
Spotlight Publication
Botensilimab (Fc-enhanced anti-CTLA-4), Balstilimab (PD-1 inhibitor)
Emerging survival plateaus with botensilimab and balstilimab: Pan tumor data from a large phase 1b trial of advanced solid tumors
Oct 17, 2025
,
Gordon et al.
ESMO
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
QS-21 STIMULON™ Adjuvant
Induction of Systemic and Mucosal Immune Responses to Human Immunodeficiency Virus Type 1 by a DNA Vaccine Formulated With QS-21 Saponin Adjuvant via Intramuscular and Intranasal Routes.
Other Articles & Publications
Journal of Virology
June 2, 2022
,
Sasaki, et al.
No items found.
QS-21 STIMULON™ Adjuvant
Oral QS-21 Requires Early IL-4 Help for Induction of Mucosal and Systemic Immunity.
Other Articles & Publications
The Journal of Immunology
June 2, 2022
,
Boyaka, et al.
No items found.
QS-21 STIMULON™ Adjuvant
Structure of the saponin adjuvant QS-21 and its Base-Catalyzed Isomerization Product by 1H and Natural Abundance 13C NMR Spectroscopy.
Other Articles & Publications
Carbohydrate Research
June 2, 2022
,
Jacobsen, et al.
No items found.
QS-21 STIMULON™ Adjuvant
Saponins as Vaccine Adjuvants.
Other Articles & Publications
Critical Reviews in Therapeutic Drug Carrier Systems
June 2, 2022
,
Kensil, CR.
No items found.